Navigation Links
VIA Pharmaceuticals Set to Join Russell Microcap Index

ome cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:

-- our ability to obtain necessary financing;

-- our ability to control our operating expenses;

-- our ability to recruit and enroll patients for the FDG-PET clinical


-- failure to obtain sufficient data from enrolled patients that can be

used to evaluate VIA-2291, thereby impairing the validity or

statistical significance of our clinical trials;

-- our ability to successfully complete our clinical trials of VIA-2291 on

expected timetables and the outcomes of such clinical trials;

-- complexities in designing and implementing cardiovascular clinical

trials using histological examinations, measurement of biomarkers,

medical imaging and atherosclerotic plaque bioassays;

-- the results of our clinical trials, including without limitation, with

respect to the safety and efficacy of VIA-2291;

-- the outcome of any legal proceedings;

-- our ability to obtain necessary FDA approvals;

-- our ability to successfully commercialize VIA-2291;

-- our ability to obtain and protect our intellectual property related to

our product candidates;

-- our potential for future growth and the development of our product


-- our ability to form and maintain collaborative relationships to develop

and commercialize our product candidates;

-- general economic and business conditions; and

-- the other risks described under Item IA "Risk Factors" in our Annual

Report on Form 10-K for the fiscal year ended December 31, 2007 on file

with the SEC.

All forward-looking statements attributable to us or persons acting on our be

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Wyeth Pharmaceuticals Announces Organizational Change
2. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
3. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
4. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
5. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
6. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
7. Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
8. Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
9. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
10. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
11. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015   Intrexon Corporation ... biology, today announced the appointment of Joseph L. ... Sector, succeeding Nir Nimrodi who continues in ... will direct Intrexon,s endeavors to generate sustainable, biologically based ... , where he held a variety of key ...
(Date:10/8/2015)... 8, 2015 Celemics, a global pioneer of ... North American market with the establishment of Celemics America, ... Europe , has secured itself in ... methodology and sample preparation for DNA sequencing and genetic ... and somatic genetic testing more accurately, quickly, and cost ...
(Date:10/8/2015)... WASHINGTON , Oct. 8, 2015  The ALS ... The ALS Assistive Technology Challenge to revolutionize communication technology ... --> --> ALS (amyotrophic lateral sclerosis) ... cells) in the brain and the spinal cord. Eventually, ... control muscle movement, which often leads to total paralysis ...
(Date:10/8/2015)... ... October 08, 2015 , ... ProMIS Neurosciences, Inc. ... to develop and commercialize intellectual property rights belonging to The University of British ... and affords exclusive worldwide rights to intellectual property based on use of the ...
Breaking Biology Technology:
... WEST LAFAYETTE, Ind. - A team of Purdue University ... that has successfully created ultrapure material that captures new ... quantum computing. The material, gallium arsenide, is used ... the laws of single-particle physics, but instead are governed ...
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today reported ... For the second quarter ended June 30, 2011, Sangamo reported ... share, compared to a net loss of $3.9  million, or ... of June 30, 2011, the company had cash, cash equivalents ...
... NEW YORK, July 27, 2011 Keryx Biopharmaceuticals, Inc. ... patient enrollment in its Phase 3 registration trial of ... cancer.  This Phase 3 trial, with over 430 randomized ... Assessment (SPA) with the Food and Drug Administration (FDA) ...
Cached Biology Technology:
(Date:9/10/2015)... -- Report Details Emerging Biological Drugs ... Revenue Prospects to Help You Stay Ahead ... drug classes? Get the latest technological and commercial ... data and industry knowledge, benefitting your influence. And ... sales predictions. Visiongain,s new study reveals what,s ...
(Date:9/10/2015)... ATLANTA , Sept. 10, 2015 ... Cleveland Clinic Wellness to create an interactive, image-based ... self-service health and wellness kiosk.  The unique assessment ... Age"— a number that suggests an individual,s biological ... biometric values as measured by the kiosk. ...
(Date:9/9/2015)... Columbia , Sept. 9, 2015  NuData ... organizational and solution-based milestones, furthering the company,s commitment ... of online fraud. NuData Security,s online ... enhancing the company,s growth cycle. The product combines ... to determine good user behavior from fraudulent behavior, ...
Breaking Biology News(10 mins):
... June 30, 2011 Jerusalem, Israel The Israeli ... industrial R&D and innovation, has released new data from ... and strategic consulting firm Applied Economics Ltd., to mark ... anniversary. The study presents the proven impact of ...
... many plastic cards currently crowd your wallet, one day ... The Department of Homeland Security(DHS),s Science and Technology Directorate ... a portable device used for measuring exposure to ionizing ... unlikely event of a nuclear accident or dirty bomb. ...
... Calif. Susan R. Wessler , who holds ... distinguished professor of genetics in the Department of ... California, Riverside, has been named the recipient of the ... ) 2012 Excellence in Science Award. The award ...
Cached Biology News:
TNM-FH Insect Medium 1 liter...
D.R. Harper (1993) • Includes: essential information on taxonomy, culture and safe handling of viruses, immunology, monoclonal antibodies, antivirals and vaccines....
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
Biology Products: